CDK 4/6 Inhibitors and Stereotactic Radiation in the Management of Hormone Receptor-Positive Breast Cancer Brain Metastases
Potluri T, Figura N, Oliver D, Robinson T, Etame A, Tran N, Liu J, Soliman H, Forsyth P, Sahebjam S, Yu M, Han H, Ahmed K. CDK 4/6 Inhibitors and Stereotactic Radiation in the Management of Hormone Receptor-Positive Breast Cancer Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e86. DOI: 10.1016/j.ijrobp.2019.06.2358.Peer-Reviewed Original Research